Case Type: Mergers & Acquisitions

SunLink Health Systems, Inc. (NYSE: SSY), relating to the proposed merger with Regional Health Properties, Inc. Under the terms of the agreement, Regional will provide one share of Regional common stock and one share of Series D Preferred Stock for each five SunLink common shares. SunLink shareholders will own approximately 43.0% of the combined company.

FuboTV, Inc. (NYSE: FUBO), relating to the proposed merger with The Walt Disney Company. Under the terms of the agreement, Disney will combine its Hulu + Live TV Business with Fubo, forming a combined MVPD company. At closing Disney will own 70% of Fubo.

Despegar.com, Corp. (NYSE: DESP), relating to the proposed merger with Prosus. Under the terms of the agreement, Prosus will acquire Despegar for $19.50 per share in an all-cash transaction, representing an enterprise value of approximately $1.7 billion for Despegar.

Nordstrom, Inc. (NYSE: JWN), relating to the proposed merger with Norse Holdings, Inc. Under the terms of the agreement, each share of Nordstrom’s common stock will be converted to $24.25 in cash.

Singular Genomics Systems, Inc. (NASDAQ: OMIC), relating to the proposed merger with Deerfield Management Company, L.P. Under the terms of the agreement, Deerfield will acquire Singular Genomics in an all-cash transaction for $20.00 per share.

NeueHealth, Inc. (NASDAQ: NEUE), relating to the proposed merger with New Enterprise Associates. Under the terms of the agreement, holders of NeueHealth common stock will receive $7.33 per share in cash.

Maiden Holdings, Ltd. (NASDAQ: MHLD), relating to the proposed merger with Kestrel Group LLC. Under the terms of the agreement, each issued and outstanding common share of Maiden will be converted into the right to receive one common share in the combined company.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), relating to the proposed merger with Immedica Pharma AB. Under the terms of the agreement, Immedica will acquire outstanding shares of Marinus common stock for a cash purchase price of $0.55 per share.

Vacasa, Inc. (NASDAQ: VCSA), relating to the proposed merger with Casago. Under the terms of the agreement, Casago will acquire all outstanding shares of Vacasa held by public stockholders at a price of $5.02 per share.

Vincerx Pharma, Inc. (NASDAQ: VINC), relating to the proposed merger with Oqory, Inc. Under the terms of the agreement, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold 5%.